US.HUM · Humana

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.3,
      "details": {
        "atrPct": 3.518725794589649,
        "turnoverUsdM": 724.55542959332,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.6,
    "stopLevels": {
      "symbol": "US.HUM",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 368.6058,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 1,
        "rsi_score": 2,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.5,
      "stop_loss_percent": 7,
      "take_profit_price": 439.4825,
      "target_multiplier": 2.2,
      "technical_strength": 2.1,
      "take_profit_percent": 10.8
    },
    "positionPoints": 1.3,
    "stopLossPoints": 1.2,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.5346464360203844,
    "stopLossPercent": 7.037451589179298,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 75,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 58,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 17
  },
  "market": {
    "ma20": 390.21,
    "ma50": 386.2792,
    "close": 396.51,
    "prevClose": 404.27,
    "avgVolume20": 1191642,
    "volumeRatio": 1.53,
    "changePercent": -1.92
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 17,
    "details": {
      "ret_5d": 0.039154020516444676,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 17,
      "vcp_bonus": 0,
      "vol_ratio": 1.590491857499717,
      "ret_points": 8,
      "vol_points": 6,
      "range_ratio": 1.1063067985321806,
      "volat_points": 0,
      "day_range_pct": 0.03830924722430084,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 75,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.9,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 58,
        "contribution": 2.9
      },
      {
        "raw": 10.8,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 54,
        "contribution": 10.8
      },
      {
        "raw": 9.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 61.33,
        "contribution": 9.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.1,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 61,
        "contribution": 6.1
      },
      {
        "raw": 23,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 76.67,
        "contribution": 23
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "觀望",
    "result": 58,
    "details": [
      "基本面分析總分: 2.9/5分",
      "資金流分析總分: 10.8/20分",
      "市場環境分析總分: 9.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.1/10分",
      "技術信號分析總分: 23/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.9,
      "資金流": 10.8,
      "市場環境": 9.2,
      "情緒分析": 4,
      "技術信號": 23,
      "風險管理": 6.1
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 724.55542959332,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 0.8,
          "obvPoints": 4,
          "vwapPoints": 3.2,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.HUM",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 733.7774982500001,
                "ma50": 721.45199924,
                "name": "QQQ",
                "close": 757.72998,
                "points": 2
              },
              "spy": {
                "ma20": 766.4579982500001,
                "ma50": 765.94739824,
                "name": "SPY",
                "close": 777.21997,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.518725794589649,
          "atrPoints": 2,
          "cciPoints": 3.2,
          "vixPoints": 0,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.8
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142695110,
                "url": "https://finnhub.io/api/news?id=b33aff18fa22f01db94e755f9d61096eaad5f652c70e88c19dcd7b9ffc05de13",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana has logged a sharp year to date rise in its share price, and that move now puts extra focus on whether the current valuation lines up with what the business earns. After such a run, the key issue for any holder or potential buyer is how much of those earnings are already reflected in the US$404.27 price tag. With Humana up 52.9% year to date, a lot now hinges on whether its earnings are strong and resilient enough to support that kind of re-rating. New Medicare Advantage coverage...",
                "category": "company",
                "datetime": 1791378491,
                "headline": "Is Humana (HUM) Stock Priced For Its Stronger Earnings Outlook?"
              },
              {
                "id": 142499520,
                "url": "https://finnhub.io/api/news?id=8f3d7d9cd0e4b07afb5248c2cc765876b17ee11acc5ba1426933083b8e631a0f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "What a time it’s been for Humana. In the past six months alone, the company’s stock price has increased by a massive 136%, reaching $391.06 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.",
                "category": "company",
                "datetime": 1790698562,
                "headline": "3 Reasons HUM Has Explosive Upside Potential"
              },
              {
                "id": 142443091,
                "url": "https://finnhub.io/api/news?id=a58edb79880cef55fb168c4221ed3e1d3bf6519e46e8f6db8ccccabf029534ab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) moved sharply higher this week after Barclays shifted its rating on the insurer to Overweight from Equalweight, indicating that the shares could outperform sector peers. At around US$397.93, Humana’s recent 4.63% 1 day share price return and 3.21% 30 day share price return build on a strong year to date share price return of 50.46%. However, the 3 year total shareholder return has declined 15.34%, suggesting the latest upgrade is being read as a fresh shift in sentiment rather...",
                "category": "company",
                "datetime": 1790474934,
                "headline": "Humana (HUM) Jumped, But What Is Drawing Fresh Attention Now?"
              },
              {
                "id": 142432687,
                "url": "https://finnhub.io/api/news?id=f0b8a5e6ce06eb93cf3259e023de36cbb273540a60b805a268172c8af0497c7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Shares of health insurance company Humana (NYSE:HUM) jumped 8% in the afternoon session after Barclays upgraded the stock from Equalweight to Overweight.",
                "category": "company",
                "datetime": 1790390437,
                "headline": "Why Humana (HUM) Stock Is Up Today"
              },
              {
                "id": 142158658,
                "url": "https://finnhub.io/api/news?id=808fc4c2ae05c8c77f35414fe4592e4035831fd5e3c07746867bac02ffd8c224",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana has staged a sharp rebound in 2024, and with the stock closing at US$407.02, the big question is whether that move still lines up with what the business earns. With the share price up 53.9% year to date, a lot of future expectations are already riding on Humana's earnings power. New research on integrated specialty pharmacy and the push toward lower drug costs may support more stable margins and cash flows, provided Humana can keep members engaged in these models. The analysts...",
                "category": "company",
                "datetime": 1789463559,
                "headline": "Humana (HUM) Stock Could Trade At A Discount Following Its 54% Rebound"
              },
              {
                "id": 142029915,
                "url": "https://finnhub.io/api/news?id=a3f21a82f91c178faa0f4bc8487cc5be3663f08d7ba39cae1a62306d768a3c3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "On August 11, Humana Inc. (NYSE:HUM) announced that its Medicaid plan, Humana Healthy Horizons in Indiana, is collaborating with HealthStream, Inc. (NASDAQ:HSTM). The partnership expands access to workforce training for caregivers, aiming to recruit and retain talent in rural and underserved communities. While one provides healthcare coverage and the other builds the software to train […]",
                "category": "company",
                "datetime": 1788986449,
                "headline": "Is HealthStream (HSTM) a Better Healthcare Bet Than Humana (HUM) Right Now?"
              }
            ],
            "raw_source": [
              {
                "id": 142700523,
                "url": "https://finnhub.io/api/news?id=dc2312e29f5c1784ca2a83e96ef9fdd7c6bdf3b29550a1ace7c5df07048c4453",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Improving Medicare Advantage ratings isn’t easy. Stars are based on 40-some criteria that encompass patient experience surveys and a range of care metrics.",
                "category": "company",
                "datetime": 1791402240,
                "headline": "Humana Faces Medicare ‘Stars’ Rating. The Result Will Test the Stock."
              },
              {
                "id": 142698432,
                "url": "https://finnhub.io/api/news?id=7b41a39e576b9b9bb47a5350123331a168e5e3491f20cb7d241f26d5b1b8f3e7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "On October 4, Suze Orman, the personal finance author and former CNBC host, had a warning for her podcast listeners covered by UnitedHealth Group (NYSE:UNH): “If you have UnitedHealth Group, about 390,000 people are part of plans that are shutting down.” She said Humana (NYSE:HUM) will cut plans covering about 600,000 people. She also said […]",
                "category": "company",
                "datetime": 1791394956,
                "headline": "Suze Orman Warned 390,000 People Their Medicare Plans Are Shutting Down, Then CNBC Called the Same Stock a Turnaround"
              },
              {
                "id": 140420211,
                "url": "https://finnhub.io/api/news?id=c9045c53ac19ad80d94a07c2e8320fa134ac76c18ad5824d79898864952688d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Intel downgraded, Marvell upgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1791381613,
                "headline": "Intel downgraded, Marvell upgraded: Wall Street's top analyst calls"
              },
              {
                "id": 142695110,
                "url": "https://finnhub.io/api/news?id=b33aff18fa22f01db94e755f9d61096eaad5f652c70e88c19dcd7b9ffc05de13",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana has logged a sharp year to date rise in its share price, and that move now puts extra focus on whether the current valuation lines up with what the business earns. After such a run, the key issue for any holder or potential buyer is how much of those earnings are already reflected in the US$404.27 price tag. With Humana up 52.9% year to date, a lot now hinges on whether its earnings are strong and resilient enough to support that kind of re-rating. New Medicare Advantage coverage...",
                "category": "company",
                "datetime": 1791378491,
                "headline": "Is Humana (HUM) Stock Priced For Its Stronger Earnings Outlook?"
              },
              {
                "id": 142694944,
                "url": "https://finnhub.io/api/news?id=f88b1d392de6d0ac795c602a741e4ff70abec533c22f4581c4bef87ac0b715f5",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/07/Netapp-Sign--Logo-On-Headquarters-Buildi.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Analysts upgraded NetApp, Humana, Corteva, Afya, with price-target changes for four stocks.",
                "category": "company",
                "datetime": 1791362383,
                "headline": "This NetApp Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday"
              },
              {
                "id": 142694602,
                "url": "https://finnhub.io/api/news?id=fa0021416f14c567615a213398376d6f9dc6f3207145ebafca93424aea24d09e",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/07/Micron.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Wall Street analysts revised targets: upgrades for NetApp and Humana; downgrades for PJT Partners; mixed target changes for Redwood, Marvell, Yum and S&P",
                "category": "company",
                "datetime": 1791361187,
                "headline": "Micron To Rally Around 187%? Here Are 10 Top Analyst Forecasts For Wednesday"
              },
              {
                "id": 142696749,
                "url": "https://finnhub.io/api/news?id=2e2457dd122fc3bcb3af4b7a60791f7284973a9304823073ea86bd0c3ba9f4f6",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Cantor Fitzgerald  analyst Sarah James   upgrades Humana (NYSE:HUM) from Neutral to Overweight and raises the price target from $300 to $460.",
                "category": "company",
                "datetime": 1791355376,
                "headline": "Cantor Fitzgerald Upgrades Humana to Overweight, Raises Price Target to $460"
              },
              {
                "id": 142666812,
                "url": "https://finnhub.io/api/news?id=c0adbfa82ff4cfa37f123929df94f6f2d6c0188132fd12ed523bd0d84ea51e90",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UNH heads into Q3 with investors focused on whether medical-cost gains can hold as Medicare Advantage margins improve without deeper member losses.",
                "category": "company",
                "datetime": 1791304020,
                "headline": "UnitedHealth Q3 Coming Up: Two Questions Investors Can't Ignore"
              },
              {
                "id": 142665593,
                "url": "https://finnhub.io/api/news?id=250795b088b35ed1b82bfdb6b49d9d54ec1117504f6d0546c96de0ab5b934acd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CNC is narrowing its 2027 Medicare Advantage footprint as elevated costs pressure plan economics, with a sharper focus on dual eligibles.",
                "category": "company",
                "datetime": 1791296880,
                "headline": "Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated"
              },
              {
                "id": 142663323,
                "url": "https://finnhub.io/api/news?id=95f1faa95146151c01f31844b05db7dbcb1e88d23ddf167623a47bd8456bfe9f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., October 06, 2026--Humana Inc. (NYSE: HUM) and the University of Louisville today announced the publication of a new economic impact report examining Humana’s contributions across the state. The analysis, authored by University of Louisville applied economist Thomas E. Lambert, PhD, found that Humana’s operations generated nearly $20 billion in economic activity across Kentucky in 2025, supporting jobs, businesses and communities throughout the Commonwealth.",
                "category": "company",
                "datetime": 1791288000,
                "headline": "Humana Generates Nearly $20 Billion in Economic Impact Across Kentucky, New Report Finds"
              },
              {
                "id": 142663322,
                "url": "https://finnhub.io/api/news?id=ca19ff8708afd153bc07ba8276e065ae2b6d6ed442369f084304b272e7b08e4f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "SALT LAKE CITY, October 06, 2026--BlueWind Medical, a leader in Implantable Tibial Neuromodulation (ITNM) and developer of the Revi® System, a patient-centric solution for urgency urinary incontinence (UUI), today announced that Humana will provide coverage for implantable tibial neuromodulation therapy for the treatment of UUI, including the Revi System, effective October 1, 2026.",
                "category": "company",
                "datetime": 1791288000,
                "headline": "BlueWind Medical Announces Humana Coverage of Revi® for Urgency Urinary Incontinence, Expanding Access to Millions of Patients"
              },
              {
                "id": 142636847,
                "url": "https://finnhub.io/api/news?id=e5de032ddfcb0fdbf2c3348f48f71c794a031187f2b158070a007e9417f129df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth is exiting select Medicare Advantage plans for 2027 as rising medical costs pressure profitability, reshaping its membership mix.",
                "category": "company",
                "datetime": 1791211680,
                "headline": "UNH Exits Select Medicare Advantage Plans for 2027 Amid Cost Pressure"
              },
              {
                "id": 142631811,
                "url": "https://finnhub.io/api/news?id=da55aad324fd9ceffd24274ae959ad1cf69a0032fb3ad954e18ac8e696f3d24f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.",
                "category": "company",
                "datetime": 1791192180,
                "headline": "1 Large-Cap Stock on Our Buy List and 2 Facing Challenges"
              },
              {
                "id": 142615678,
                "url": "https://finnhub.io/api/news?id=7ef08fe76ddf72e9df18b9ea1c012b45000fec56025cac6973ff9ffef0bc70d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Insurers are adapting to shifting market conditions with aggressive cost-cutting measures.",
                "category": "company",
                "datetime": 1791043380,
                "headline": "The Insurance Industry Is Shedding Jobs. It’s Not All About AI."
              },
              {
                "id": 142591887,
                "url": "https://finnhub.io/api/news?id=95659ce457d3c5238beca1a4664dd95f6733e39c74c397a8f6dd45402365a0aa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS Health's Aetna and Centene are also shrinking their Medicare Advantage offerings as insurers pull back from less profitable markets",
                "category": "company",
                "datetime": 1790961961,
                "headline": "UnitedHealth and Humana cutting Medicare Advantage plans in 2027"
              },
              {
                "id": 142590823,
                "url": "https://finnhub.io/api/news?id=9115cffdd0f5bac173da39794cc5c9f299323af696eb8ae7bfd68296ddb6f1a6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Key Stats for UnitedHealth StockCurrent Price: $365. 20Target Price (Mid): ~$586Street Target: ~$482Potential Total Return: ~61%Annualized IRR: ~12% / yearWhat Happened?UnitedHealth Group (UNH:NYSE) is shutting Medicare Advantage plans that cover about 390,000 people for 2027, a company spokesperson told Bloomberg on October 1.",
                "category": "company",
                "datetime": 1790954035,
                "headline": "UnitedHealth Trades at $365 as It Shuts Plans for 390,000 Medicare Advantage Members. Here’s What It Signals for 2027"
              },
              {
                "id": 142581267,
                "url": "https://finnhub.io/api/news?id=8c783d54f798f8baba878d1a33d3bd74c4603a700c35efe48cef11b208f1c6a7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS Health (CVS) stock lost 12.7% in the past month without company news, and peers UnitedHealth, Cigna and Elevance Health fell too. The S&P 500 rose 0.6% over the same month. The shares now trade 22.5% below their 52-week high. How much further could CVS stock fall if the market itself turns down.",
                "category": "company",
                "datetime": 1790929464,
                "headline": "How Much Downside Is Left In CVS Health Stock?"
              },
              {
                "id": 142562076,
                "url": "https://finnhub.io/api/news?id=d67a2ead5d6046b322da961befefd5bb1027a86893a9f3f29bb38753b5252215",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana already told investors in July how many members it plans to drop. What your neighbor with a surviving plan has not figured out yet is how quietly the costs on that plan changed before open enrollment closes Dec. 7.",
                "category": "company",
                "datetime": 1790879458,
                "headline": "Humana Reports Third-Quarter Earnings Nov. 6, in the Middle of Open Enrollment. Members Got Their Plan-Change Letters Weeks Earlier. Wall Street Got the Numbers in July"
              },
              {
                "id": 142556734,
                "url": "https://finnhub.io/api/news?id=3937a61f4210b68e9dade13ac2178b91cfc79da0cca8618c1cc9b88bdc7156e8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., October 01, 2026--As Medicare’s Annual Election Period (AEP) begins Oct. 15, Humana is offering 2027 Medicare Advantage plans designed to deliver high-value coverage with affordable monthly premiums. Members will have continued access to the benefits they value most – including $0 cost-sharing on in-network primary care visits and labs plus dental, vision, and hearing coverage. Additional 2027 highlights include:",
                "category": "company",
                "datetime": 1790852400,
                "headline": "Humana Maintains Affordable Medicare Advantage Plans and Expands Specialized Care Options for 2027"
              },
              {
                "id": 142558566,
                "url": "https://finnhub.io/api/news?id=659f93818e056e16c3aa2ab5ded2d76ebde2f49b88d69d32e28d7d37ad2cab29",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Additional 2027 highlights include:Medicare Advantage plans in approximately 2,600 counties across 45 states and Washington, D.C., representing more than 80% of U.S. counties.Expanded Chronic Condition Special Needs",
                "category": "company",
                "datetime": 1790838482,
                "headline": "Humana To Offer 2027 Medicare Advantage Plans With Continued Access To The Benefits, Including $0 Cost-Sharing On In-Network Primary Care Visits And Labs Plus Dental, Vision, And Hearing From October 15"
              },
              {
                "id": 142500417,
                "url": "https://finnhub.io/api/news?id=235745f2ec56182ee07c85a38d1c9a880f6d5ddce34e70ce68a6175f09891376",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth (UNH) stock trades at 22.5 times its past year's adjusted earnings, which are normalized net income with stock-based pay added back. That multiple leaves little room for error after three years of shrinking operating margins, sitting near the stock's 10-year median despite fundamentally weaker profitability. But the price looks different against the profit expected for fiscal 2026 and fiscal 2027. So what are UnitedHealth investors betting on.",
                "category": "company",
                "datetime": 1790706345,
                "headline": "What Are UNH Stock Investors Betting On?"
              },
              {
                "id": 142499520,
                "url": "https://finnhub.io/api/news?id=8f3d7d9cd0e4b07afb5248c2cc765876b17ee11acc5ba1426933083b8e631a0f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "What a time it’s been for Humana. In the past six months alone, the company’s stock price has increased by a massive 136%, reaching $391.06 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.",
                "category": "company",
                "datetime": 1790698562,
                "headline": "3 Reasons HUM Has Explosive Upside Potential"
              },
              {
                "id": 142498204,
                "url": "https://finnhub.io/api/news?id=1fadd9409892b197cf4a6a4a6d2ac7ceb70dc26e036272850d4db43f80d48aa9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth shareholders spent five years waiting for a stock that barely budged, yet something inside the company kept growing the whole time. Whether that something is enough to make UNH worth holding now depends on costs that management has not yet fully tamed.",
                "category": "company",
                "datetime": 1790690898,
                "headline": "UnitedHealth Stock Has Gone Nowhere for Five Years. Its Dividend Has Not"
              },
              {
                "id": 142443091,
                "url": "https://finnhub.io/api/news?id=a58edb79880cef55fb168c4221ed3e1d3bf6519e46e8f6db8ccccabf029534ab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) moved sharply higher this week after Barclays shifted its rating on the insurer to Overweight from Equalweight, indicating that the shares could outperform sector peers. At around US$397.93, Humana’s recent 4.63% 1 day share price return and 3.21% 30 day share price return build on a strong year to date share price return of 50.46%. However, the 3 year total shareholder return has declined 15.34%, suggesting the latest upgrade is being read as a fresh shift in sentiment rather...",
                "category": "company",
                "datetime": 1790474934,
                "headline": "Humana (HUM) Jumped, But What Is Drawing Fresh Attention Now?"
              },
              {
                "id": 142432687,
                "url": "https://finnhub.io/api/news?id=f0b8a5e6ce06eb93cf3259e023de36cbb273540a60b805a268172c8af0497c7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Shares of health insurance company Humana (NYSE:HUM) jumped 8% in the afternoon session after Barclays upgraded the stock from Equalweight to Overweight.",
                "category": "company",
                "datetime": 1790390437,
                "headline": "Why Humana (HUM) Stock Is Up Today"
              },
              {
                "id": 142425534,
                "url": "https://finnhub.io/api/news?id=497c05dbdd185b5daee0e5704ea3d188104bc74edbd1c42af5529f74a5fd3b55",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Healthcare stocks rose late Friday afternoon with the NYSE Healthcare Index increasing 0.3% and the",
                "category": "company",
                "datetime": 1790365811,
                "headline": "Sector Update: Healthcare Stocks Higher Late Afternoon"
              },
              {
                "id": 142425310,
                "url": "https://finnhub.io/api/news?id=b26709e0a9895e9dabe9e7d0cd4238a29c761ebd827ec7d7cdc10dcfa2dff969",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.",
                "category": "company",
                "datetime": 1790363101,
                "headline": "Top S&P500 movers in Friday's session"
              },
              {
                "id": 142425635,
                "url": "https://finnhub.io/api/news?id=cc4bdd8652f900fee558578f88668f84196a101998a77f33f53b723da84b8379",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Investing.com -- Humana Inc. (NYSE:HUM) shares rose 6% Friday after Barclays upgraded the health insurer to overweight from equal-weight ahead of the upcoming Medicare Star ratings release.",
                "category": "company",
                "datetime": 1790362782,
                "headline": "Humana surges: Barclays bets big on Medicare star ratings rebound"
              },
              {
                "id": 142425122,
                "url": "https://finnhub.io/api/news?id=0d41d472a3c61877a78173ca1812c78e13c4a7ab5ff1180522c81f12f81fe3e9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Barclays just broke its silence on Humana with a conviction call that sent shares surging well past anything the broader health care sector is doing today, raising the question of whether this upgrade signals the start of something bigger or a rally built on a single opinion.",
                "category": "company",
                "datetime": 1790359149,
                "headline": "Humana Jumps 7% on Barclays Upgrade and $515 Target; UnitedHealth Nudges Higher"
              },
              {
                "id": 142424342,
                "url": "https://finnhub.io/api/news?id=934105b468350b5d32bbeacccbde6d0bf0f602402f2458bf63ad1cd8b5c90e5c",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Get insights into the S&P500 index performance on Friday. Explore the top gainers and losers within the S&P500 index in today's session.",
                "category": "company",
                "datetime": 1790354101,
                "headline": "Discover which S&P500 stocks are making waves on Friday."
              },
              {
                "id": 142424936,
                "url": "https://finnhub.io/api/news?id=de2a50debecd5a9b78bc22b537fe263eaaee9cb722d5f42e9eb2154e7d9c7d13",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Barclays upgraded Humana stock to Overweight from Neutral and raised its price target to $515 from $407.",
                "category": "company",
                "datetime": 1790352540,
                "headline": "Humana Stock Jumps. Why It Could Be a Big Winner in Next Medicare Star Ratings."
              },
              {
                "id": 142437401,
                "url": "https://finnhub.io/api/news?id=ad0db2f0cba0ca406add338bdd82f007e8b4746106bec86a39fae04943436d63",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/25/Copenhagen--Denmark---August-3--2019-3m-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Analysts upgraded First Financial, 3M, Synopsys, Humana and Stem, raising targets for four while maintaining Stem’s $7 target.",
                "category": "company",
                "datetime": 1790347621,
                "headline": "This 3M Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday"
              },
              {
                "id": 140701481,
                "url": "https://finnhub.io/api/news?id=01e6e03b84a7b35aac28fb47af397adbda237de6cf33812e0a2da0c0696c1ae4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "IBM upgrade, SpaceX initiation among today's top calls on Wall Street",
                "category": "company",
                "datetime": 1790343814,
                "headline": "IBM upgrade, SpaceX initiation among today's top calls on Wall Street"
              },
              {
                "id": 142421430,
                "url": "https://finnhub.io/api/news?id=eecd41dedad803ee95bc80410630c118848c067cdb6306e7be95cb266425763c",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.",
                "category": "company",
                "datetime": 1790339700,
                "headline": "Wondering what's happening in today's S&P500  pre-market session?"
              },
              {
                "id": 142438361,
                "url": "https://finnhub.io/api/news?id=59db29e229fb50824677effdce5ce61e6e93999fcf821e67c1867cf2b07cf3a2",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Barclays  analyst Andrew Mok   upgrades Humana (NYSE:HUM) from Equal-Weight to Overweight and raises the price target from $407 to $515.",
                "category": "company",
                "datetime": 1790336298,
                "headline": "Barclays Upgrades Humana to Overweight, Raises Price Target to $515"
              },
              {
                "id": 142437666,
                "url": "https://finnhub.io/api/news?id=0ee6b5f40888c3b2506f45b8472989257b4ee9f302493f3db5fb118e6c7ea69a",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/25/Display-Of-Stock-Market-Quotes.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "U.S. stocks rose Friday; Akamai jumped 8.1% on an $11.6B Anthropic cloud deal, while Atlas Energy, Almonty and others posted strong gains.",
                "category": "company",
                "datetime": 1790335052,
                "headline": "Akamai, Atlas Energy Solutions, People And Other Big Stocks Moving Higher On Friday"
              },
              {
                "id": 142384683,
                "url": "https://finnhub.io/api/news?id=c21395e30aacf5f3bd20fbf13e9006f0d6a4e0d20793588da316f5b79e250925",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "If you own CVS Health (CVS), the primary focus shifts from 2026 execution toward potential headwind variables heading into 2027. Management raised its 2026 earnings outlook on its fiscal Q2 2026 call in August. It also gave an early read on 2027, a quarter sooner than usual. One warning in that read came with no number. Over the past three months, the shares lost 15.2%, while the S&P 500 gained 5.0%. What is the 2027 problem CVS would not put a number on.",
                "category": "company",
                "datetime": 1790267681,
                "headline": "What Should CVS Stock Investors Be Watching Now?"
              },
              {
                "id": 142365220,
                "url": "https://finnhub.io/api/news?id=dd32755ec590d1799b7d5ec3ad6f92a43dd03c670e0a73958df4dc85ca5cfada",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "By Exec Edge Editorial Staff Health insurance premiums have climbed for years. Deductibles have climbed right along with them. Yet a growing number of American households are choosing neither, opting instead for a decades-old alternative, which is not health insurance, built around monthly contributions and community values. “People are clearly paying high premiums now,” Liberty […] The post Liberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Pod",
                "category": "company",
                "datetime": 1790197600,
                "headline": "Liberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Podcast"
              },
              {
                "id": 142363187,
                "url": "https://finnhub.io/api/news?id=b94d47bbce0ea7953955a6a923c93c2c6a1272c92b020e9b95530b838666b05c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth Group (UNH) stock has risen about 40% since late March 2026, against close to 19% for the S&P 500. Read cold, that looks like a recovery nobody could have timed. It was not hidden. The company had said plainly, months before the shares turned, that it would give up members to rebuild margin.",
                "category": "company",
                "datetime": 1790180809,
                "headline": "Did UnitedHealth Name The Fix Before Its Stock Ran?"
              },
              {
                "id": 142355707,
                "url": "https://finnhub.io/api/news?id=4662ff75c5601db13998990c5ce991658817bef5e0713a0262b52a0544bdaa8b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Toronto, Ontario--(Newsfile Corp. - September 23, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) (OTCQB: TMPTF) (\"TempraMed\" or the \"Company\"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce it has entered into a distribution agreement dated August 25, 2026 (the \"Distribution Agreement\") with CenterWell Pharmacy, Inc. (\"CenterWell\") the pharmacy services brand of Humana Inc, a major U.S. health...",
                "category": "company",
                "datetime": 1790147100,
                "headline": "TempraMed Announces Distribution Agreement with CenterWell Pharmacy(R), the Pharmacy Services Brand of Humana"
              },
              {
                "id": 142342070,
                "url": "https://finnhub.io/api/news?id=34b69edf2a74f0cb424507a082f3bdd474474b0b9314bc154e1fc4d76ca78ba1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth (UNH) has turned its profits around. Operating earnings rose 55% in the second quarter of 2026, and management raised its full-year adjusted earnings guide to $19.50 to $20 a share. Revenue, though, has nearly stopped growing. So the rest of the recovery rests on something the company only partly controls: the medical bills of the people it insures.",
                "category": "company",
                "datetime": 1790100599,
                "headline": "Can UNH Stock Keep Growing Earnings While Its Sales Stall?"
              },
              {
                "id": 142315098,
                "url": "https://finnhub.io/api/news?id=8dc65a87533f54ae58d8fefcc45dfb7d67a5bd4c66cf394114b9b5116ce49f36",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.",
                "category": "company",
                "datetime": 1790017501,
                "headline": "Monday's session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 142259580,
                "url": "https://finnhub.io/api/news?id=89921bae1997322422e9319a30a5dd8a72284387734060c40f8b39cb717d64b1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CI is expanding AI across care coordination and specialty pharmacy as it seeks to manage elevated healthcare costs and improve access.",
                "category": "company",
                "datetime": 1789742520,
                "headline": "Can Cigna's AI Push Help Rein In Rising Healthcare Costs?"
              },
              {
                "id": 142253967,
                "url": "https://finnhub.io/api/news?id=cc96e85bcbd3f911ee04bc5faedce46fa69ce08f2304cc6523cc0ba700260543",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS Health (CVS) keeps a little over a penny of profit from every dollar it takes in. A net margin of 1.2% reads like a verdict on the business. On $415.1 billion of revenue, one point of net margin is worth over $4 billion, and 1.2% is closer to a floor than a peak. Management has been working on it through 2026.",
                "category": "company",
                "datetime": 1789733701,
                "headline": "Should You Buy CVS Stock For The Margin Aetna Is Rebuilding?"
              },
              {
                "id": 142253117,
                "url": "https://finnhub.io/api/news?id=e11028fe46d2f48c6ef48e72b060b54606b0ee35c8994be445e30b364af77ec5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.",
                "category": "company",
                "datetime": 1789727560,
                "headline": "2 Unpopular Stocks That Should Get More Attention and 1 We Question"
              },
              {
                "id": 142231473,
                "url": "https://finnhub.io/api/news?id=30df880a56c5295e42ccef56f6654b312adc745dad00fe838d58243ab584a373",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CNC's profitability is recovering, but rising margins face a key test as Medicaid membership declines and eligibility reviews continue.",
                "category": "company",
                "datetime": 1789659000,
                "headline": "Can Centene Sustain Its Turnaround Amid Membership Pressure?"
              },
              {
                "id": 142223782,
                "url": "https://finnhub.io/api/news?id=d822589fb641971cc9ec09849131d713771573965270318e8d0134de30ce5826",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., September 17, 2026--A new research study finds an association between pharmacy care coordination services and improved health outcomes for cancer patients.",
                "category": "company",
                "datetime": 1789646460,
                "headline": "New Humana research finds association between pharmacy care coordination services and improved health outcomes for cancer patients"
              },
              {
                "id": 142213885,
                "url": "https://finnhub.io/api/news?id=4c0c1b40c39b4cd3cde08377f58d6a5a0e9a8ef017f648fcbdfe8c5296450c0c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "When the Federal Reserve lifts rates and signals they may stay elevated for years, the easy-growth playbook breaks. Cash flows today matter more than promises tomorrow, and investors start to care a lot about balance sheet strength, pricing power and dependable dividends. This article walks through three large cap quality defensive stocks that screen well under those rules and explains how the latest Fed move could affect each one. The three stocks below are a sample of what this quality...",
                "category": "company",
                "datetime": 1789629223,
                "headline": "3 Health Care Stocks Built For Higher Rates"
              },
              {
                "id": 142231472,
                "url": "https://finnhub.io/api/news?id=4dc012de61c556e431b75d6fea82414e40a3feefd245b616e30e4e566497774f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Americans on Medicare Advantage plans may soon get a breakup letter in the mail: Your insurer is canceling your plan.  Humana  and other Advantage insurers are sending letters this fall to plan members about 2027 coverage.  As insurers look to cut costs, some are discontinuing their Advantage plans.",
                "category": "company",
                "datetime": 1789624800,
                "headline": "Losing Your Medicare Plan? There’s a Silver Lining."
              },
              {
                "id": 142198233,
                "url": "https://finnhub.io/api/news?id=62893c934108390cb4e84f708579862ec5e7b3b4291db08db0f2465e4946203f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth's repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.",
                "category": "company",
                "datetime": 1789579013,
                "headline": "The One Cost Line UnitedHealth Stock Has Not Caught Up To Yet"
              },
              {
                "id": 142195393,
                "url": "https://finnhub.io/api/news?id=3b6bdf092a40c927edad0623e8edc6e5b71ea42aeeb8a305c4b1d7ce904318a9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., September 16, 2026--Humana Inc. (NYSE: HUM) today announced the results of Humana Community Day 2026, the company’s annual nationwide day of service. In its third year, Humana Community Day mobilized more than 18,000 employees across 28 states and Puerto Rico, supported 1,200 nonprofit organizations, and positively impacted 2.25 million lives and community members through volunteer projects focused on food security, neighborhood revitalization, environmental stewardship and soci",
                "category": "company",
                "datetime": 1789560000,
                "headline": "Humana Community Day 2026 Generates 2.2 Million Meals and Community Investments Nationwide"
              },
              {
                "id": 142160447,
                "url": "https://finnhub.io/api/news?id=4b9006c710441c6abe75ec2c80a73863bb98fbc34d77513d5450c84b1e5fbe3b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "DUBLIN, Ohio, September 15, 2026--Quantum Health, the industry-leading healthcare navigation company, today announced the appointment of Susan Mani, M.D., as Chief Medical Officer. Dr. Mani will shape Quantum Health's clinical strategy, working to improve healthcare experiences, results and affordability for members and clients.",
                "category": "company",
                "datetime": 1789475400,
                "headline": "Quantum Health Names Dr. Susan Mani as Chief Medical Officer"
              },
              {
                "id": 142160446,
                "url": "https://finnhub.io/api/news?id=d67ac2dbf48f6d0dd329d1ab5d26bad186d15e36a2775d4b1c565d6f5111cfbb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "NEW YORK, September 15, 2026--CalmiGo, developer of the first and only mental health platform that provides immediate relief and long-term care to users suffering from anxiety, PTSD, and panic attacks, announces today that its platform has been selected for CMS’s ACCESS program, offering technology-supported chronic care for behavioral health conditions. Medicare serves over 70 million patients and created the ACCESS program to expand access to technology-supported chronic care. Fourteen additio",
                "category": "company",
                "datetime": 1789470000,
                "headline": "CalmiGo Selected for CMS’s ACCESS Program to Provide Technology-Supported Chronic Care for Behavioral Health Conditions"
              },
              {
                "id": 142158658,
                "url": "https://finnhub.io/api/news?id=808fc4c2ae05c8c77f35414fe4592e4035831fd5e3c07746867bac02ffd8c224",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana has staged a sharp rebound in 2024, and with the stock closing at US$407.02, the big question is whether that move still lines up with what the business earns. With the share price up 53.9% year to date, a lot of future expectations are already riding on Humana's earnings power. New research on integrated specialty pharmacy and the push toward lower drug costs may support more stable margins and cash flows, provided Humana can keep members engaged in these models. The analysts...",
                "category": "company",
                "datetime": 1789463559,
                "headline": "Humana (HUM) Stock Could Trade At A Discount Following Its 54% Rebound"
              },
              {
                "id": 142148504,
                "url": "https://finnhub.io/api/news?id=109a37c3b4773b9929db5c05c3b3c1772031edcc000e87fd9e98d6856be6a6c6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana listed Counterpart Health among the vendors for its provider-performance and quality programs.",
                "category": "company",
                "datetime": 1789438099,
                "headline": "CLOV Stock Hits Over 2-Month High As Humana Deal Buzz Builds Ahead Of Investor Conferences"
              },
              {
                "id": 142141425,
                "url": "https://finnhub.io/api/news?id=1319d644a68d1a16e7a0fdb153103e0f98cb9c4ea9eee6a94f946c434dcaf49d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The health care giant showered its owners with cash, yet the stock spent years in the slow lane. Here’s the accounting of what that trade-off actually delivered.",
                "category": "company",
                "datetime": 1789420257,
                "headline": "CVS Stock Returned $24B In Cash: Why Did It Still Lag The Market?"
              },
              {
                "id": 142141467,
                "url": "https://finnhub.io/api/news?id=40c7ec190f17456e6d4cedac5eaa7a53021f0b8cfbc64b185ac0b994c06ac9e3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth (UNH) has spent the past year repairing margins rather than chasing growth. The shares rebounded well ahead of any actual margin recovery: up about 38% over the past six months, though down about 6% over the past three, and still behind the S&P 500 over the past twelve months, 12.2% for the stock against 18.6% for the index. What argues for owning them now shows up in cash running ahead of reported profit.",
                "category": "company",
                "datetime": 1789414884,
                "headline": "Should You Buy UNH Stock Because Its Cash Runs Ahead Of Its Profit?"
              },
              {
                "id": 142088659,
                "url": "https://finnhub.io/api/news?id=bdc2f3449be06089f2a7a0fff4946e8fcf53edb531611c3d7f202790ddc443c0",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will",
                "category": "company",
                "datetime": 1789133712,
                "headline": "10 Health Care Stocks With Whale Alerts In Today’s Session"
              },
              {
                "id": 142064801,
                "url": "https://finnhub.io/api/news?id=986a6117d59e8175d3255bd7bd52028ee01dd339371ca80d62205c5bea18363a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.",
                "category": "company",
                "datetime": 1789069012,
                "headline": "Should You Buy Elevance Health Stock For The Margin It Lost?"
              },
              {
                "id": 142063328,
                "url": "https://finnhub.io/api/news?id=0ddaecaced7b45415c54683e8f459cfc0dd0f482dcb3ec10e83497f59326cbf3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.",
                "category": "company",
                "datetime": 1789061100,
                "headline": "UnitedHealth Reshapes Florida WellMed Operations With TPG Deal"
              },
              {
                "id": 142062099,
                "url": "https://finnhub.io/api/news?id=5ef3409d6896f45882c982d485a19acdb3f58328a0fe0fbafc647d8ddf483972",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., September 10, 2026--A new peer-reviewed study from Humana Healthcare Research published in Health Affairs Scholar found that Medicare Advantage beneficiaries who used an integrated specialty pharmacy, which coordinates pharmacy services with a beneficiary’s health plan, experienced faster access to specialty medications and lower out-of-pocket pharmacy costs compared with beneficiaries using non-integrated specialty pharmacies. The research suggests that greater coordination bet",
                "category": "company",
                "datetime": 1789048800,
                "headline": "New Study Links Integrated Specialty Pharmacy Care to Faster Access and Lower Costs"
              },
              {
                "id": 142060930,
                "url": "https://finnhub.io/api/news?id=2e74443f51fae12373b55f78e2aa434fd344482bd09547fc850da95b2f997f90",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "BrightSpring Health Services' Specialty and Infusion sales rose 30%, backed by LDD growth, new launches and expansion into rare therapies.",
                "category": "company",
                "datetime": 1789045980,
                "headline": "BTSG's Specialty Pharmacy Sales Up 30%: Will the Growth Continue?"
              },
              {
                "id": 142029915,
                "url": "https://finnhub.io/api/news?id=a3f21a82f91c178faa0f4bc8487cc5be3663f08d7ba39cae1a62306d768a3c3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "On August 11, Humana Inc. (NYSE:HUM) announced that its Medicaid plan, Humana Healthy Horizons in Indiana, is collaborating with HealthStream, Inc. (NASDAQ:HSTM). The partnership expands access to workforce training for caregivers, aiming to recruit and retain talent in rural and underserved communities. While one provides healthcare coverage and the other builds the software to train […]",
                "category": "company",
                "datetime": 1788986449,
                "headline": "Is HealthStream (HSTM) a Better Healthcare Bet Than Humana (HUM) Right Now?"
              },
              {
                "id": 142028659,
                "url": "https://finnhub.io/api/news?id=0081c272b61c689e1879a429e5f7c5cd199146ca47c277f5122abab9309cdee1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.",
                "category": "company",
                "datetime": 1788982210,
                "headline": "Why Is UNH Stock Trading At A Premium With The Slowest Growth?"
              },
              {
                "id": 142025948,
                "url": "https://finnhub.io/api/news?id=40dfd9205ae43e624ebad1b59d50330d3017274c720b1d7abe70d6b8ef8c5fe4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UNH is investing nearly $1.5B in AI to expand Optum Insight's software offerings, boost efficiency and unlock new growth opportunities.",
                "category": "company",
                "datetime": 1788967800,
                "headline": "Can UnitedHealth's AI Strategy Strengthen Optum Insight's Growth?"
              },
              {
                "id": 142029916,
                "url": "https://finnhub.io/api/news?id=3966d13a5e361af4bd335e93fb8462237491ffa516fecce2986dba7d99b8387f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana has outperformed the broader Dow Jones index over the past year. Moreover, Wall Street analysts remain moderately optimistic about its prospects.",
                "category": "company",
                "datetime": 1788965754,
                "headline": "Is Humana Stock Outperforming the Dow?"
              },
              {
                "id": 142025949,
                "url": "https://finnhub.io/api/news?id=1e60277542dd68ec98f2ca5040753093f4e61bd880edcdf64de9408c92768f2e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped was healing.",
                "category": "company",
                "datetime": 1788964814,
                "headline": "UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation"
              },
              {
                "id": 142024396,
                "url": "https://finnhub.io/api/news?id=fee7ff8411d4d6ec06d6d4910d7f911dd35d3fd361ea815c362df264666f9d36",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.",
                "category": "company",
                "datetime": 1788957301,
                "headline": "Stay updated with the S&P500 stocks that are on the move in today's pre-market session."
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 6,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.8,
            "source_article_count": 68,
            "discarded_article_count": 62
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 23,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.9,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50；升放量(近10日3日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 1067086.6666666667,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1348770,
              "avg_vol_20": 1148910,
              "avg_vol_30": 1067086.6666666667,
              "range_pct_10": 0.11207790189206075,
              "range_pct_20": 0.12821870499561921,
              "range_pct_30": 0.12821870499561921,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 3,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.2639741851645914,
              "dist_to_20d_high": 0.055861109126842404,
              "down_shrink_days": 1,
              "breakout_level_20d": 419.97,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.8741150668764753
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 4,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.3,
            "details": {
              "atrPct": 3.518725794589649,
              "turnoverUsdM": 724.55542959332,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.6,
          "stopLevels": {
            "symbol": "US.HUM",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 368.6058,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 1,
              "rsi_score": 2,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.5,
            "stop_loss_percent": 7,
            "take_profit_price": 439.4825,
            "target_multiplier": 2.2,
            "technical_strength": 2.1,
            "take_profit_percent": 10.8
          },
          "positionPoints": 1.3,
          "stopLossPoints": 1.2,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.5346464360203844,
          "stopLossPercent": 7.037451589179298,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.HUM",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 13.9521,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.52
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "適中偏強",
      "score": 8,
      "value": 63.45
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1574
    },
    "kdj": {
      "d": 49.42,
      "j": 73.39,
      "k": 57.41,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 38.39
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 806268,
      "recentSlope": -120663.2,
      "previousSlope": -116900
    },
    "rsi": 56.48,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 375.7621,
      "position": "SAR喺價下",
      "distancePct": 5.23,
      "previousTrend": "上升"
    },
    "ma50": 386.2792,
    "macd": {
      "macd": 1.3907372435877505,
      "trend": "強烈看漲",
      "signal": -0.25793291767312193,
      "histogram": 1.6486701612608725
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 8,
      "value": 392.0059,
      "position": "連續3日>VWAP",
      "consecutiveAbove": 3
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.53,
      "score": 6,
      "avgVolume": 1191642,
      "currentVolume": 1827332
    },
    "derived": {
      "ma20": 390.21,
      "ma50": 386.2792,
      "prevClose": 404.27,
      "avgVolume10": 1451643,
      "avgVolume20": 1191642,
      "changePercent": -1.92,
      "avgVolumeForScore": 1191642
    },
    "ma_cross": {
      "ma20": 390.21,
      "ma50": 386.2792,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 390.3855,
      "prevMa50": 386.1232,
      "spreadPct": 1.02,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 368.3522,
      "upper": 412.0678,
      "position": "上半部"
    },
    "rsi_short": 62.19,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.53
    }
  }
}

{
  "close": 396.51,
  "volume": 1827332,
  "changePercent": -1.92
}